Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 (CEACAM6) Peptide
CEACAM6
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all CEACAM6 products
- CEACAM6 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 (CEACAM6))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- EIQNPASANR SDPVTLNVLY GPDGPTISPS KANYRPGENL NLSCHAASNP
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CEACAM6 antibody,
Alternative Names: CEACAM6 control peptide, CEACAM6 antibody Blocking Peptide, Anti-CEACAM6 Blocking Peptide, Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 Blocking Peptide, CD66c Blocking Peptide, CEAL Blocking Peptide, NCA Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- CEACAM6 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 (CEACAM6))
- Background
- Many breast, pancreatic, colonic and non-small-cell lung carcinoma lines express CEACAM6 and CEACAM5, and antibodies to both can affect tumor cell growth in vitro and in vivo. CEACAM6 expression is elevated in many solid tumors, but variable as a function of histotype. It may be a promising target for antibody-based therapy.
- Molecular Weight
- 38 kDa
-
You are here:
